|Bid||53.02 x 1000|
|Ask||53.03 x 1100|
|Day's range||52.35 - 53.35|
|52-week range||32.00 - 83.11|
|Beta (5Y monthly)||1.77|
|PE ratio (TTM)||9.05|
|Forward dividend & yield||2.04 (3.86%)|
|Ex-dividend date||31 Jul 2020|
|1y target est||N/A|
Citi, acting through Citibank N.A., has been appointed by Freeline Therapeutics Holdings plc ("Freeline"), a clinical-stage gene therapy company, to act as depositary bank for its American Depositary Receipt ("ADR") programme.
Citi has been selected to provide custody and tax services by CAVALI S.A. ICLV S.A., the central securities depository (CSD) for the Lima Stock Exchange for $6 billion of dual-listed securities. The dual listing platform of the Lima Stock Exchange (BVL) and CAVALI provides investors with access to international securities and is critical to the development of the local capital markets.
Citi today announced its new five-year 2025 Sustainable Progress Strategy to help accelerate the transition to a low-carbon economy. This new strategy includes a $250 Billion Environmental Finance Goal to finance and facilitate climate solutions globally. This builds on Citi’s previous $100 billion goal announced in 2015 and completed last year, more than four years ahead of schedule.